TGFB1 and glomerulosclerosis: In summary, the ability of pyridoxamine to reverse a fibrotic marker of glomerulosclerosis (TGFβ) and ERα expression in aged female mice (21 months old) suggests that oxidant stress-related damage in the aging kidney is reversible.